You are here

Nass Valley Gateway Ltd.

Nass Valley Gateway Ltd.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
NVG
CSE Index: 
Currency: 
Nass Valley Gateway has completed the acquisition of two wholly owned subsidiaries Advanced Bioceuticals Limited (“ABL”), incorporated under the Laws of New Jersey and Pro-Thotics Technology Inc. (“PTI”), a New York corporation with a more than 25 year established business. Through its subsidiary PTI the Company will continue to focus on expanding the sale of Durable Medical Equipment (“DME-Products”)and increasing its database of more than 200,000 patients with service of providing relief from pain and medical issues via its DME-Products. Through its subsidiary ABL the Company is determined to expand upon this pain relief concept and to commence the sale of Cannabidiol (CBD) with zero THC content for internal use including CBD infused skin, bath, and body care products.

You are here

Nass Valley Gateway Ltd. (NVG)

SEDAR Information

Company Info

Address
Suite 170, 422 Richards St.
Vancouver, BC V6B 2Z4
Canada
Phone
1-609-651-0032
Email
info@nassvalleygateway.com
Website
http://www.nassvalleygateway.com
Listing date
Friday, March 9, 2007
Transfer Agent
Integral Transfer Agency Shareholder Services
Investor Relations
Michael Semler
Email
michael.s@nassvalleygateway.com
Auditor
Manning Elliot Chartered Accountants

Capitalization

Issued & Outstanding: 
312143477
Reserved for Issuance: 
17026542

Bulletins

21/11/2023

2023-1123 - Reinstatement - Nass Valley Gateway Ltd. (NVG)

le 21 Novembre/November2023

Effective immediately, Nass Valley Gateway Ltd. will be reinstated for trading.

The Company has rectified the situation that gave rise to the suspension.

____________________________

À compter d'aujourd'hui, Nass Valley Gateway Ltd. sera réintégré à la négociation.

La Société a rectifié la situation qui a donné lieu à la suspension.